Giant Papillary Conjunctivitis Clinical Presentation
- Author: Barry A Weissman, OD, PhD, FAAO; Chief Editor: Hampton Roy Sr, MD more...
History
Patients with giant papillary conjunctivitis (GPC) often report an increase in contact lens soilage, ocular itching, and mucous discharge in tears, as well as blurred vision and conjunctival injection. This can be accompanied by decreased contact lens tolerance and mechanical stability.
Physical Examination
Clinicians commonly note increased deposition on contact lenses. Also, contact lenses appear to ride higher under the upper lids than expected. Rigid lenses in particular, show deposits around the lens edge.
With eversion of the lids, inflammation of the vasculature (hyperemia) and papillary hypertrophy are noted. (See the images below.)
Very large papillae in the everted upper lid of a patient who wears hydrogel (soft) contact lenses.
Giant papillary conjunctivitis (GPC) response (slightly out of focus) seen in the upper lid of a young patient recovering from cataract extraction with an exposed suture barb (in focus). Mucous strands can be seen in the tears and between the papillae.
Papillae can range from small, uniform lesions (uniform cobblestone appearance [UCA]) to irregular changes (nonuniform cobblestone appearance [NUCA]) to clusters of giant lesions with whitish centers that can ulcerate and stain with sodium fluorescein dye.[11] Originally, the papillae of the upper tarsal conjunctiva were thought to have to be at least 1 mm to diagnose giant papillary conjunctivitis. Today, the clinical sign is generally accepted as follows: the papillae are at least 0.3 mm in diameter on the upper palpebral conjunctiva in association with the classic symptoms.
Giant papillary conjunctivitis that is associated with hydrogel contact lenses is more commonly at the fold of the everted lid, spreading over the entire tarsal conjunctival surface.
Giant papillary conjunctivitis that is associated with rigid contact lens wear shows an opposite pattern, corresponding to the position of the contact lens edge meeting the lid tissues. This is evidence for the mechanical etiology hypothesis.
Silicone hydrogel lenses tend to induce more local than general giant papillary conjunctivitis responses, similar to that seen with rigid lens wear.
Attending eye doctors should routinely invert and visually inspect lids, especially if a patient who wears contact lenses has any ocular complaints.
Subjective ocular itching, mucus, contact lenses with significant protein deposits, and contact lenses that become less comfortable, more mobile, or ride higher underneath the upper lids should all raise suspicion of giant papillary conjunctivitis.
Spring TF. Reaction to hydrophilic lenses. Med J Aust. Mar 23 1974;1(12):449-50. [Medline].
Allansmith MR, Korb DR, Greiner JV. Giant papillary conjunctivitis induced by hard or soft contact lens wear: quantitative histology. Ophthalmology. Aug 1978;85(8):766-78. [Medline].
Allansmith MR, Ross RM. Giant papillary conjunctivitis. Int Ophthalmol Clin. 1988;28(4):309-16.
Donshik PC, Ehlers WH, Ballow M. Giant papillary conjunctivitis. Immunol Allergy Clin North Am. Feb 2008;28(1):83-103, vi. [Medline].
Forister JF, Forister EF, Yeung KK, Ye P, Chung MY, Tsui A, et al. Prevalence of contact lens-related complications: UCLA contact lens study. Eye Contact Lens. Jul 2009;35(4):176-80. [Medline].
Dunn JP Jr, Weissman BA, Mondino BJ, Arnold AC. Giant papillary conjunctivitis associated with elevated corneal deposits. Cornea. Oct 1990;9(4):357-8. [Medline].
Jones L, Senchyna M, Glasier MA, Schickler J, Forbes I, Louie D, et al. Lysozyme and lipid deposition on silicone hydrogel contact lens materials. Eye Contact Lens. Jan 2003;29(1 Suppl):S75-9; discussion S83-4, S192-4. [Medline].
Skotnitsky CC, Naduvilath TJ, Sweeney DF, Sankaridurg PR. Two presentations of contact lens-induced papillary conjunctivitis (CLPC) in hydrogel lens wear: local and general. Optom Vis Sci. Jan 2006;83(1):27-36. [Medline].
Donshik PC. Giant papillary conjunctivitis. Trans Am Ophthalmol Soc. 1994;92:687-744. [Medline]. [Full Text].
Donshik PC, Ballow M, Luistro A, Samartino L. Treatment of contact lens-induced giant papillary conjunctivitis. CLAO J. Oct-Dec 1984;10(4):346-50. [Medline].
Allansmith MR, Korb DR, Greiner JV, Henriquez AS, Simon MA, Finnemore VM. Giant papillary conjunctivitis in contact lens wearers. Am J Ophthalmol. May 1977;83(5):697-708. [Medline].
Irani AM, Burtus I, Tabbar KF, et al. Human conjunctival mast cells; distribution of MCT and MCTC in vernal conjunctivitis and giant papillary conjunctivitis. J Allergy Clin Immunol. 1990;86(1):34-40.
Greiner JV, Covington HI, Allansmith MR. Surface morphology of the human upper tarsal conjunctiva. Am J Ophthalmol. Jun 1977;83(6):892-905. [Medline].
Abelson MB, Soter NA, Simon MA, Dohlman J, Allansmith MR. Histamine in human tears. Am J Ophthalmol. Mar 1977;83(3):417-8. [Medline].
Donshik PC, Ballow M. Tear immunoglobulins in giant papillary conjunctivitis induced by contact lenses. Am J Ophthalmol. Oct 1983;96(4):460-6. [Medline].
Ballow M, Donshik PC, Mendelson I. Complement proteins and C3 anaphylatoxin in the tears of patients with contact lens associated conjunctivitis. J Allergy Clin Immunol. 1985;76(3):473-6.
Szczotka LB, Cocuzzi E, Medof ME. Decay-accelerating factor in tears of contact lens wearers and patients with contact lens-associated complications. Optom Vis Sci. Nov 2000;77(11):586-91. [Medline].
Ballow M, Donshik PC, Rapacz P, Samartino L. Tear lactoferrin levels in patients with external inflammatory ocular disease. Invest Ophthalmol Vis Sci. Mar 1987;28(3):543-5. [Medline].
Rapacz P, Tedesco J, Donshik PC, Ballow M. Tear lysozyme and lactoferrin levels in giant papillary conjunctivitis and vernal conjunctivitis. CLAO J. Oct-Dec 1988;14(4):207-9. [Medline].
Elgebaly SA, Donshik PC, Rahhal F, Williams W. Neutrophil chemotactic factors in the tears of giant papillary conjunctivitis patients. Invest Ophthalmol Vis Sci. Jan 1991;32(1):208-13. [Medline].
Irkeç MT, Orhan M, Erdener U. Role of tear inflammatory mediators in contact lens-associated giant papillary conjunctivitis in soft contact lens wearers. Ocul Immunol Inflamm. Mar 1999;7(1):35-8. [Medline].
Moschos MM, Eperon S, Guex-Crosier Y. Increased eotaxin in tears of patients wearing contact lenses. Cornea. Nov 2004;23(8):771-5. [Medline].
Zhong X, Liu H, Pu A, Xia X, Zhou X. M cells are involved in pathogenesis of human contact lens-associated giant papillary conjunctivitis. Arch Immunol Ther Exp (Warsz). May-Jun 2007;55(3):173-7. [Medline]. [Full Text].
Bartlett JD, Howes JF, Ghormley NR, Amos JF, Laibovitz R, Horwitz B. Safety and efficacy of loteprednol etabonate for treatment of papillae in contact lens-associated giant papillary conjunctivitis. Curr Eye Res. Apr 1993;12(4):313-21. [Medline].
Khurrana S, Sharma N, Agorwal T, et al. Comparison of Olopatadine and Fluorometholone in contact lens-induced papillary conjunctivitis. Eye and Contact Lens. 2010;36(4):210-4.
Korb DR, Greiner JV, Finnemore VM, Allansmith MR. Treatment of contact lenses with papain. Increase in wearing time in keratoconic patients with papillary conjunctivitis. Arch Ophthalmol. Jan 1983;101(1):48-50. [Medline].
Kruger CJ, Ehlers WH, Luistro AE, Donshik PC. Treatment of giant papillary conjunctivitis with cromolyn sodium. CLAO J. Jan 1992;18(1):46-8. [Medline].

